Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate.
Short-chain fatty acids (SCFAs) are potent modulators of the growth, function, and differentiation of intestinal epithelia. In addition, high-fiber diets may protect against the development of atherosclerosis because of their cholesterol-lowering effects due, in large part, to SCFA production, liver sterol metabolism, and bile acid excretion. Although the small gut plays a major role in dietary fat transport and contributes substantially to plasma cholesterol and lipoprotein homeostasis, the impact of SCFAs on intestinal lipid handling remains unknown. In the present study, the modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein secretion by butyrate was investigated in Caco-2 cells plated on permeable polycarbonate filters, which permit separate access to the upper and lower compartments of the monolayers. Highly differentiated and polarized cells (20 days of culture) were incubated for 20 h with 20 mM butyrate in the apical medium. In the presence of [14C]oleic acid, butyrate led to a significant reduction of secreted, labeled triglycerides (27%; P < 0.01) and phospholipids (25%; P < 0.05). Similarly, butyrate significantly decreased the incorporation of [14C]acetate into exported cholesteryl ester (49%; P < 0.005). As expected from these results, with [14C]oleic acid as a precursor, butyrate significantly (P < 0.05) diminished the delivery of radiolabeled chylomicrons and very low-density lipoproteins. In parallel, [35S]methionine pulse labeling of Caco-2 cells revealed the concomitant inhibitory effect of butyrate on the synthesis of apolipoproteins B-48 (28%; P < 0.05) and A-I (32%; P < 0.01). Collectively, our data indicate that butyrate may influence lipid metabolism in Caco-2 cells, thus suggesting a potential regulation of intestinal fat absorption and circulating lipoprotein concentrations.
Department of Nutrition, Centre de Recherche, Hôpital Sainte-Justine, Université de Montréal, Québec, Canada H3T 1C5.
Valérie
V
Marcil
Edgard
E
Delvin
Ernest
E
Seidman
Lucie
L
Poitras
Monika
M
Zoltowska
Carole
C
Garofalo
Emile
E
Levy
D001053:Apolipoproteins / Q000096:biosynthesis*; D002087:Butyrates / Q000494:pharmacology*; D018938:Caco-2 Cells; D002784:Cholesterol / Q000096:biosynthesis; D004951:Esterification / Q000187:drug effects; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis*; D008074:Lipoproteins / Q000378:metabolism*; D019301:Oleic Acid / Q000494:pharmacology; D011499:Protein Processing, Post-Translational / Q000187:drug effects*
D001053:Apolipoproteins; D002087:Butyrates; D008055:Lipids; D008074:Lipoproteins; D019301:Oleic Acid; D019344:Lactic Acid; D002784:Cholesterol